Contact
Please use this form to send email to PR contact of this press release:
Kaskela Law LLC Announces Shareholder Investigation of Fate Therapeutics, Inc. (NASDAQ: FATE) and Encourages Long-Term FATE Shareholders to Contact the Firm
TO: